Invention Application
- Patent Title: CCR5-BASED METHODS FOR PREDICTING OVERALL AND PROGRESSION FREE SURVIVAL IN SUBJECTS HAVING CANCER
-
Application No.: US17430457Application Date: 2020-02-13
-
Publication No.: US20220128544A1Publication Date: 2022-04-28
- Inventor: Daniel L. ADAMS , Cha-Mei TANG
- Applicant: Creatv MicroTech, Inc.
- Applicant Address: US MD Potomac
- Assignee: Creatv MicroTech, Inc.
- Current Assignee: Creatv MicroTech, Inc.
- Current Assignee Address: US MD Potomac
- International Application: PCT/US2020/018074 WO 20200213
- Main IPC: G01N33/50
- IPC: G01N33/50 ; G01N33/574
Abstract:
Means for predicting overall survival (OS) and progression free survival (PFS) of subjects having cancer are disclosed, where the predictions are based on the number of CCR5 pools in circulating cells, such as circulating cancer associated macrophage-like cells (CAMLs) and circulating tumor cells (CTCs) found in a biological sample, such as blood, from the subject. CCR5 expression can also be used for companion or complementary diagnostics.
Information query
IPC分类:
